These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4019314)

  • 1. Sugar-ring analogs of daunorubicin: 3'-epidaunorubicin, 3'-hydroxy-3',5'-diepidaunorubicin and 3',6'-dihydroxy-3',5'-diepidaunorubicin.
    Cheung TM; Horton D; Priebe W; Turner WR; Weckerle W
    J Antibiot (Tokyo); 1985 May; 38(5):683-6. PubMed ID: 4019314
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis and antitumor activity of optically active (+)-9-O-alpha-L-daunosaminyl-4-demethoxydaunorubicin.
    Kimura Y; Matsumoto T; Suzuki M; Terashima S
    J Antibiot (Tokyo); 1985 Sep; 38(9):1277-9. PubMed ID: 4066509
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytostatic activity of daunorubicin analogs containing daunosamine as furanoside.
    Kuszmann J; Medgyes G; Dvortsák P; Tory K
    Arzneimittelforschung; 1986 May; 36(5):786-9. PubMed ID: 3730013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Derivatives of antineoplastic antibiotics of the daunorubicin series containing methylurea or nitrosomethylurea residues].
    Povarov LS; Bakina EV; Lazhko EI; Orlova GI; Zhukova OS; Obidniak NA; Iurchenko GI; Glazkova TIu; Preobrazhenskaia MN
    Bioorg Khim; 1990 Apr; 16(4):559-68. PubMed ID: 2375780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antileukemic activity of N-enamine derivatives of daunorubicin, 5-iminodaunorubicin, and doxorubicin.
    Stefańska B; Dzieduszycka M; Bontemps-Gracz M; Borowski E; Martelli S
    J Antibiot (Tokyo); 1988 Feb; 41(2):193-8. PubMed ID: 3356607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced antitumor properties of 3'-(4-morpholinyl) and 3'-(4-methoxy-1-piperidinyl) derivatives of 3'-deaminodaunorubicin.
    Mosher CW; Wu HY; Fujiwara AN; Acton EM
    J Med Chem; 1982 Jan; 25(1):18-24. PubMed ID: 7086816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological activity of the two isomeric 2'-C-methyl daunomycins.
    Rocherolle V; Olesker A; Lukacs G
    J Antibiot (Tokyo); 1989 Sep; 42(9):1393-7. PubMed ID: 2793594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antitumor activity of 2'-bromo- and 2'-chloro-3'-acetoxy-3'-deaminodaunorubicin analogs.
    Horton D; Priebe W; Varela O
    Carbohydr Res; 1985 Dec; 144(2):305-15. PubMed ID: 4092209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New N-amino acid derivatives of daunorubicin.
    Dzieduszycka M; Stefanska B; Borowski E; Martelli S
    Farmaco Sci; 1986 Nov; 41(11):881-91. PubMed ID: 3803566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. o-Methylation on anthracyclines and anthracyclinones. New o-methyl ethers of daunorubicin and its analogues.
    Cassinelli G; Di Matteo F; Forenza S; Ripamonti MC; Ruggieri D; Vigevani A; Arcamone F
    Farmaco Sci; 1982 Aug; 37(8):501-13. PubMed ID: 6957317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of the structure of new anthracycline antibiotics on their biological properties.
    Wasowska M; Oszczapowicz I; Wietrzyk J; Opolski A; Madej J; Dzimira S; Oszczapowicz J
    Anticancer Res; 2005; 25(3B):2043-8. PubMed ID: 16158943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3'-Deamino-4'-epi-3'-hydroxy-daunorubicin and -doxorubicin. Synthesis and antitumor activity.
    Horton D; Priebe W; Varela O
    J Antibiot (Tokyo); 1984 Dec; 37(12):1635-41. PubMed ID: 6549317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorus-containing metabolites in anthracycline-resistant murine leukemia P388 cells.
    Shiryaeva OA; Semenova NA; Sibeldina LA; Goncharova SA; Konovalova NP
    Neoplasma; 1992; 39(4):229-32. PubMed ID: 1436233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antitumor activity of 3'-C-methyl-daunorubicin.
    Thang TT; Imbach JL; Fizames C; Lavelle F; Ponsinet G; Olesker A; Lukacs G
    Carbohydr Res; 1985 Jan; 135(2):241-7. PubMed ID: 3986844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total chemical synthesis and antitumor evaluation of 4-demethoxy-10,10-dimethyldaunomycin.
    Alexander J; Khanna I; Lednicer D; Mitscher LA; Veysoglu T; Wielogorski Z; Wolgemuth RL
    J Med Chem; 1984 Oct; 27(10):1343-7. PubMed ID: 6481770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA.
    Bodley A; Liu LF; Israel M; Seshadri R; Koseki Y; Giuliani FC; Kirschenbaum S; Silber R; Potmesil M
    Cancer Res; 1989 Nov; 49(21):5969-78. PubMed ID: 2551497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of antitumor-active 7-O-(2,6-dideoxy-2-fluoro-alpha-L-talopyranosyl)-daunomycinone and -adriamycinone.
    Ok K; Takagi Y; Tsuchiya T; Umezawa S; Umezawa H
    Carbohydr Res; 1987 Nov; 169():69-81. PubMed ID: 3427590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of tunicamycin on anthracycline resistance in P388 murine leukemia cells.
    Chou TH; Kessel D
    Biochem Pharmacol; 1981 Nov; 30(22):3134-6. PubMed ID: 6950722
    [No Abstract]   [Full Text] [Related]  

  • 19. Design, synthesis and biological activity of 7-O-(4-O-acetyl-3-iodo-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl) daunomycinone and 7-O-(3-chloro-2,3,6-trideoxy-4-O-propanoyl-alpha-L-lyxo- hexopyranosyl)daunomycinone.
    Aligiannis N; Pouli N; Marakos P; Mitaku S; Skaltsounis AL; Leonce S; Pierre A; Atassi G
    Chem Pharm Bull (Tokyo); 2000 Jan; 48(1):150-3. PubMed ID: 10705494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New anthracycline glycosides obtained by the nitrous acid deamination of daunorubicin, doxorubicin and their configurational analogues.
    Cassinelli G; Ballabio M; Arcamone F; Casazza AM; Podesta' A
    J Antibiot (Tokyo); 1985 Jul; 38(7):856-67. PubMed ID: 3861603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.